as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹132.45
Change
-2.05 (-1.52%)
Open
₹136.0
Prev. Close
₹134.5
Day High
₹136.75
Day Low
₹132.01
Volume Analysis
Traded
72,443
Delivered
44,439
Delivery %
61.34%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (2)
- •Strong return on equity (28.5%)
- •Strong operating margin (22.0%)
Weaknesses (0)
No signal for this stock
Opportunities (0)
No signal for this stock
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹140.21 | ₹138.48 | ₹135.47 | ₹133.74 | ₹130.73 | ₹129.0 | ₹125.99 |
| Fibonacci | ₹138.48 | ₹136.67 | ₹135.55 | ₹133.74 | ₹131.93 | ₹130.81 | ₹129.0 |
| Camarilla | ₹133.75 | ₹133.32 | ₹132.88 | ₹133.74 | ₹132.02 | ₹131.58 | ₹131.15 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-5.52%
1 Week
-8.69%
1 Month
-2.38%
3 Months
-12.08%
6 Months
-5.39%
1 Year
-7.58%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
DuPont ROE Breakdown
26.44%
Net margin 12.46% × asset turnover 1.04x × equity multiplier 2.04x
Company Overview
Sector
Healthcare
Market Cap
₹1,136 Cr
P/E (TTM)
27.3
ROE
28.5%
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Gpt Healthcare Limited holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 65/100. The strongest factor is Cash Flow (99/100), while Institutional Ownership (17/100) is the weakest area to weigh before deciding. Notably: Strong return on equity (28.5%); strong operating margin (22.0%). FII holding has been falling.
TopFund Score — Fundamentals Quality
65/100 — GoodData confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has reduced debt.
- +Company has been maintaining a healthy dividend payout of 53.9%
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Audio recording of investor call on Q2 and H1 FY2026-27 unaudited results uploaded.
Copies of the News Paper publication on Un-Audited Financial Results for Q2 & H1 FY 27 and Notice of Record Date.
GPT Healthcare reported H1 FY27 income of Rs 266.8 crore, PAT Rs 28.1 crore, up 53.9%.
Investor Presentation on Un-Audited Financial Results for the Q2 & H1 FY27.
Source: BSE regulatory filings, via Screener.in.
Profit & Loss (Yearly)
| Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|
| Sales + | 212 | 243 | 337 |
| Expenses + | 176 | 194 | 263 |
| Operating Profit | 36 | 49 | 74 |
| OPM % | 17.0% | 20.0% | 22.0% |
| Other Income + | 4 | 6 | 5 |
| Interest | 14 | 14 | 11 |
| Depreciation | 11 | 12 | 14 |
| Profit before tax | 15 | 29 | 54 |
| Tax % | 26.0% | 27.0% | 23.0% |
| Net Profit + | 11 | 21 | 42 |
| EPS in Rs | 1 | 3 | 5 |
| Dividend Payout % | 0.0% | 47.0% | 115.0% |
| Sales growth | — | 15 | 39 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|
| Reserves | 109 | 116 | 78 |
| Borrowings + | 157 | 163 | 96 |
| Other Liabilities + | 25 | 20 | 70 |
| Total Liabilities | 308 | 317 | 323 |
| Fixed Assets + | 226 | 220 | 220 |
| CWIP | 2 | 0 | 1 |
| Investments | 1 | 1 | 10 |
| Other Assets + | 80 | 97 | 92 |
| Total Assets | 308 | 317 | 323 |
| Equity Capital | 18 | 18 | 80 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|
| Cash from Operating Activity + | 41 | 43 | 66 |
| Cash from Investing Activity + | -54 | -16 | -5 |
| Cash from Financing Activity + | 12 | -22 | -57 |
| Net Cash Flow | -1 | 4 | 3 |
| Free Cash Flow | -5 | 38 | 59 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 116 | 82 | 107 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 16.14% | 17.16% | 18.92% | 18.41% | 18.59% | 20.14% | 24.77% | 25.48% | 24.79% | 24.46% | 24.32% |
| Promoters | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% |
| FII | 6.68% | 5.38% | 4.7% | 4.71% | 4.49% | 4.96% | 3.2% | 2.73% | 2.81% | 3.03% | 3.01% |
| DII | 11.61% | 11.88% | 10.8% | 11.3% | 11.35% | 9.33% | 6.45% | 6.2% | 6.84% | 6.94% | 7.1% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Gpt Healthcare Limited (this stock) | 1,136 | 27.3 | — | 28.5% |
| Bafna Pharmaceuticals Ltd | 1,121 | — | 2.19 | -6.18% |
| 3b Blackbio Dx Ltd. | 1,157 | 19.7 | 3.33 | 19.8% |
| Sigachi Industries Ltd | 1,088 | 41.3 | 2.02 | 5.78% |
| Laxmi Dental Limited | 1,076 | 29.7 | 4.05 | 14.8% |
| Lincoln Pharma Ltd | 1,032 | 10.6 | 1.27 | 12.0% |
| Gujarat Kidney N Sup Sp L | 1,269 | 66.8 | 4.82 | 11.1% |
Which Mutual Funds Hold Gpt Healthcare Limited?
Frequently Asked Questions about Gpt Healthcare Limited
Gpt Healthcare Limited (GPTHEALTH) closed at ₹132.45 on NSE on 19 November 2026, down 2.05 (1.52%) from the previous close.
Gpt Healthcare Limited trades on the NSE (National Stock Exchange of India) under the symbol GPTHEALTH.
Gpt Healthcare Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 27.3.
Gpt Healthcare Limited has a dividend yield of 1.81%.
Gpt Healthcare Limited's 52-week high is ₹175.0 and its 52-week low is ₹114.0.
Gpt Healthcare Limited has a market capitalisation of ₹1,136 crore.
Gpt Healthcare Limited has a TopFund Quality Score of 65/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Gpt Healthcare Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.